National rating: AA+ (THA), Outlook: Stable S&P BBB+, Outlook: Stable Source and Use of Fund: 9M22 (Bt.mn) Source of fund Use of fund Operating cash flow 62,976 Dividend paid 22,871 Sale of equipment 123
July 2019, Moody’s Investors Service upgraded the Bank’s subordinated debt instrument rating to Baa2 from Baa3 and the Bank's Baseline Credit Assessment (BCA) to baa1 from baa2 and changed the outlook to
-owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor: Waiting 3. Buying the Medical Instruments The Company will appropriately make a purchase from
from buying and transferring assets THB 129.1 MB and depreciation on useful life of asset in which increase for THB 15.7 MB. Liabilities The Company’s total liabilities as of 31 December 2019 and 2018
operations Overview of the retail industry in 2019, the growth rate was not very high at approximately 2.6 percent resulting from consumer buying power was slow due to economic conditions. In which the Company
-21.785 -8.91 Profit (Loss) from Exchange Rate 4.09 4.61 0.52 12.71 1.19 0.48 0.35 -0.13 -27.08 -0.84 -70.59 Other Revenue 5.51 6.63 1.12 20.33 2.13 1.18 1.32 0.14 11.86 -0.81 -38.03 Gain from buying at a
affected to limited buying power. For the 2H17, although the government has announced policy to urge economic, the majority of policy related with investment in government and infrastructure which take a
company will be set up a wholly- owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor : N/A 3. Buying the Medical Instruments The Company will appropriately
company will be set up a wholly-owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor : N/A 3. Buying the Medical Instruments The Company will appropriately
. In addition to this, if buying a new machineries, it will take longer time to order the machine, period of installation and testing system will be more than 6 months which may cause business